Alzheimer's Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have a confirmed diagnosis of Alzheimer's disease (AD) or mild cognitive impairment (MCI), based on current diagnostic guidelines
- People who are older than 55 years of age
- People whose first language is Norwegian
- People who are living at home, not in a care home or other health institution
Who may not be able to join:
- People whose memory or thinking difficulties are severe enough to prevent completing the assessments used in this trial (confirm with trial site)
- People who have a brain tumour
- People who have a history of a brain injury caused by physical trauma, such as a head injury
- People who have previously had surgery on the skull or brain
- People who are unable to safely undergo the imaging methods used in this trial, such as a specialised type of MRI scanner (called 7T MRI) or brainwave recording (EEG)
- People who have been diagnosed with another condition affecting the brain or nervous system, such as Parkinson's disease or ALS
- People with large tattoos, permanent makeup, or piercings that cannot be removed, located near the head — as these may be incompatible with the 7T MRI scanner
- People with certain types of pacemakers (the trial site's MRI specialists would need to review the specific model before a decision is made)
- People who have metal implants in their body, such as clips, stents, joint replacements, screws, plates, or certain dental work — as these may be incompatible with the 7T MRI scanner
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Axel Sandvig Professor, MD PhD, Norwegian University of Science and Technology (NTNU)
Phone: +4745840578
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Understand which individual differences are observed among patients with Alzheimer's disease (AD).; Compare changes in the brain, blood, and stool samples between dementia patients and healthy controls.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.